Bleeding Risk in Patients with Nonvalvular AF on Rivaroxaban Increases with CHA2DS2-VASc Score

Summary and Comment |
December 2, 2016

Bleeding Risk in Patients with Nonvalvular AF on Rivaroxaban Increases with CHA2DS2-VASc Score